Preoperative Proton MR Spectroscopic Imaging of Brain Tumors: Correlation with Histopathologic Analysis of Resection Specimens

References

1. ↵
   Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;8:6-29
2. Nelson DJ, McDonald JV, Lapham LW, Qazi R, Rubin P. Central nervous system tumors. In: Rubin P, eds. Clinical Oncology A Multidisciplinary Approach for Physicians and Students. 7th ed. Philadelphia: WB Saunders Company 1993;
3. ↵
   Black P, Wen P. Clinical, imaging and laboratory diagnosis of brain tumors. In: Kaye A, Laws E, eds. Brain Tumors. New York: Churchill Livingstone 1995;
4. Giles G, Gonzales M. Epidemiology of brain tumors and factors in prognosis. In: Kaye A, Laws E, eds. Brain Tumors. New York: Churchill Livingstone 1995;
5. ↵
   Bottomley PA. Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? Radiology 1989;170:1-15

   PubMedWeb of Science
6. Cohen SM. Physiological NMR spectroscopy: from isolated cells to man. New York: New York Academy of Sciences 1987;
7. ↵
   Barker PB, Glickson JD, Bryan RN. In vivo magnetic resonance spectroscopy of human brain tumors. Top Magn Reson Imaging 1993;5:32-45

   PubMed
8. Radda GK, Bore PJ, Rajagopalan B. Clinical aspects of NMR spectroscopy. Br Med Bull 1984;40:155-160

   FREE Full Text
9. Matson GB, Weiner MW. MR spectroscopy in vivo: principles, animal studies and clinical applications. In: Stark DD, Bradley WG, eds. Magn Reson Imaging St. Louis: Mosby 1988:201-228
10. Glickson JD. Clinical NMR spectroscopy of tumors: current status and future directions. Invest Radiol 1989;24:1011-1016

    PubMedWeb of Science
11. Arle JE, Morriss C, Wang ZJ, Zimmerman RA, Phillips PG, Sutton LN. Prediction of posterior fossa tumor type in children by means of magnetic resonance image properties, spectroscopy, and neural networks. J Neurosurg 1997;86:755-761

    CrossRefPubMed
12. ↵
    Arnold D, Shoubridge E, Villemure J, Feindel W. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading. NMR Biomed 1990;3:184-189

    PubMed
13. Bárány M, Langer BG, Glick RP, Venkatasubramanian PN, Wilbur AC, Spigos DG. In vivo H-1 spectroscopy in humans at 1.5 T. Radiology 1988;167:839-844

    PubMed
14. Broniscer A, Gajjar A, Bhargava R, et al. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma. Neurosurgery 1997;40:331-338

    CrossRefPubMedWeb of Science
15. Bruhn H, Frahm J, Gyngell M, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors [see comments]. Radiology 1989;172:541-548

    PubMedWeb of Science
16. Daly PF, Cohen JS. Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review. Cancer Res 1989;49:770-779

    Abstract/FREE Full Text
17. Gill SS, Small RK, Thomas DG, et al. Brain metabolites as 1H NMR markers of neuronal and glial disorders. NMR Biomed 1989;2:196-200

    PubMed
18. Go KG, Keuter EJ, Kamman RL, et al. Contribution of magnetic resonance spectroscopic imaging and L-[1–11C]tyrosine positron emission tomography to localization of cerebral gliomas for biopsy. Neurosurgery 1994;34:994-1002

    PubMed
19. Langkowski JH, Wieland J, Bomsdorf H, et al. Pre-operative localized in vivo proton spectroscopy in cerebral tumors at 4.0 Tesla—first results. Magn Reson Imaging 1989;7:547-555

    PubMed
20. Moats RA, Watson L, Shonk T, et al. Added value of automated clinical proton MR spectroscopy of the brain. J Comput Assist Tomogr 1995;19:480-491

    PubMed
21. ↵
    Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449-458

    CrossRefPubMedWeb of Science
22. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303-324

    PubMedWeb of Science
23. Shimizu H, Kumabe T, Tominaga T, et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:737-747

    Abstract
24. Sijens PE, Knopp MV, Brunetti A, et al. ¹H MR spectroscopy in patients with metastatic brain tumors: a multicenter study. Magn Reson Med 1995;33:818-826

    CrossRefPubMedWeb of Science
25. Tzika AA, Vajapeyam S, Barnes PD. Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: preliminary observations. AJNR Am J Neuroradiol 1997;18:203-218

    Abstract
26. Tzika AA, Vigneron DB, Dunn RS, Nelson SJ, Ball WS Jr. Intracranial tumors in children: small single-voxel proton MR spectroscopy using short- and long-echo sequences. Neuroradiology 1996;38:254-263

    PubMed
27. Wang Z, Sutton LN, Cnaan A, et al. Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am J Neuroradiol 1995;16:1821-1833

    Abstract
28. Wang Z, Zimmerman RA, Sauter R. Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. AJR Am J Roentgenol 1996;167:191-199

    PubMedWeb of Science
29. ↵
    Kamada K, Houkin K, Abe H, Sawamura Y, Kashiwaba T. Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy. Neurol Med Chir 1997;37:250-256
30. Sijens PE, Vecht CJ, Levendag PC, van Dijk P, Oudkerk M. Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast. Invest Radiol 1995;30:738-744

    CrossRefPubMed
31. Taylor JS, Langston JW, Reddick WE, et al. Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Rad Oncol Biol Phys 1996;36:1251-1261

    CrossRefPubMed
32. Tien RD, Lai PH, Smith JS, Lazeyras F. Single-voxel proton brain spectrsocopy exam (PROBE/SV) in patients with primary brain tumors. AJR Am J Roentgenol 1996;167:201-209

    PubMedWeb of Science
33. Tomoi M, Kimura H, Yoshida M, et al. Alterations of lactate (+lipid) concentration in brain tumors with in vivo hydrogen magnetic resonance spectroscopy during radiotherapy. Invest Radiol 1997;32:288-296

    PubMed
34. Usenius T, Usenius JP, Tenhunen M, et al. Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int J Rad Oncol Biol Phys 1995;33:719-724

    CrossRefPubMedWeb of Science
35. ↵
    Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes; initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93

    CrossRefPubMedWeb of Science
36. Frahm J, Michaelis T, Merboldt KD, Bruhn H, Gynchell ML, Hanicke W. Improvements in localized proton NMR spectroscopy of human brain, water suppression, short echo times, and 1 ml resolution. J Magn Reson 1990;90:464-473

    Web of Science
37. Duijn JH, Matson GB, Maudsley AA, Weiner MW. 3D phase-encoding 1H spectroscopic imaging of human brain. Magn Reson Imaging 1992;10:315-319

    CrossRefPubMedWeb of Science
38. Luyten PR, Mariën AJ, den Hollander JA. Acquisition and quantitiation in proton spectroscopy. NMR Biomed 1991;4:64-69

    PubMed
39. Moonen CTW, von Kienlin M, van Zijl PCM, Cohen J, Gillen J, Daly P, Wolf G. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed 1989;2:201-208

    PubMed
40. Bottomley PA. Selective volume method for performing localized NMR spectroscopy. US patent 4 480 228 1984;
41. Damaerel P, Johannik K, Van Hecke P, et al. Localized 1H NMR spectroscopy in fifty new cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 1991;15:67-76

    PubMed
42. Alger JR, Frank JA, Bizzi A, et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 flourodeoxyglucose PET. Radiology 1990;177:633-641

    PubMedWeb of Science
43. Gill SS, Thomas DG, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumors: in vivo and in vitro studies. J Comp Assist Tomogr 1990;14:497-504

    PubMedWeb of Science
44. Kugel H, Heindel W, Ernestus RI, Bunke J, du Mesnil R, Friedman G. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992;183:701-709

    PubMedWeb of Science
45. ↵
    Barker PB, Glickson JD, Bryan RN. In vivo magnetic resonance of human brain tumors. Top Magn Reson Imaging 1993;5:32-45
46. Chang L, Mc Bride D, Miller BL, et al. Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of hetergeneous brain tumors. J Neuroimag 1995;5:157-163

    PubMed
47. McBride DQ, Miller BL, Nikas DL, et al. Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg Neurol 1995;44:137-144

    CrossRefPubMedWeb of Science
48. Usenius JP, Kauppinen RA, Vaino P, et al. Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro. J Comp Assist Tomogr 1994;18:705-713

    PubMed
49. Usenius JP, Vaino P, Hernesniemi J, Kauppinen RA. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem 1994;63:1538-1543

    PubMedWeb of Science
50. Heesters MA, Kamman RL, Mooyaart EL, Go KG. Localized proton spectroscopy of in operable brain tumuors. Response to radiation therapy. J Neuro-Oncol 1993;17:27-35

    CrossRefPubMed
51. Segebarth CM, Baleriaux DF, Luyten PR, den Hollander JA. Detection of metabolic heterogeneity of human intracranial tumors in vivo by H-1 NMR spectroscopic imaging. Magn Reson Med 1990;13:62-76

    PubMedWeb of Science
52. Luyten PR, Marien AJ, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990;176:791-799

    PubMedWeb of Science
53. ↵
    Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686

    PubMed
54. Go KG, Keuter EJ, Kamman RL, et al. Contribution of magnetic resonance spectroscopic imaging and L-[1-¹¹C]Tyrosine positron emission tomography to localization of cerebral gliomas for biopsy. Neurosurgery 1994;34:994-1002
55. Preul MC, Caramanos Z, Collins DL, et al. Accurate non-invasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2:323-325

    CrossRefPubMedWeb of Science
56. ↵
    Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991;45:37-45

    CrossRefPubMedWeb of Science
57. Petroff O, Spencer D, Alger J, Prichard J. High-field proton magnetic resonance spectrsocopy of human cerebrum obtained during surgery for epilepsy. Neurology 1989;39:1197-1202

    Abstract/FREE Full Text
58. Urenjak J, Williams S, Gadian D, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989

    Abstract
59. ↵
    Peeling J, Sutherland G. High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 1992;24:123-136

    PubMedWeb of Science
60. Kinoshita Y, Kajiwara H, Yokota A, Koga Y. Proton magnetic resonance spectroscopy of astrocytic tumors: an in vitro study. Neurol Med Chir 1993;33:350-359
61. Kinoshita Y, Kajiwara H, Yokota A, Koga Y. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery 1994;35:606-613

    PubMedWeb of Science
62. Rutter A, Hugenholtz H, Saunders JK, et al. Classification of brain tumors by ex vivo 1H NMR spectroscopy. J Neurochem 1995;64:1655-1661

    PubMedWeb of Science
63. ↵
    Michaelis T, Merboldt KD, Bruhn H, Hänicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Neuroradiology 1993;187:219-227
64. ↵
    McDermott MW, Gutin PH, Edwards MSB, Barbaro NM, Dillon WP, Wilson CB. Frameless stereotactic neurosurgery: clinical experience using the ISG wand. Can J Neurol Sci 1994;21: (Suppl.2) 16
65. McDermott MW. Image guided surgery. In: Berstein M, Berger MS, eds. Essentials in Neuro-Oncology New York: Thieme Medical Publishers 2000;
66. ↵
    Nelson SJ, Nalbandian AB, Proctor E, Vigneron DB. Registration of images from sequential MR studies of the brain. J Magn Reson Imaging 1994;4:877-883

    PubMedWeb of Science
67. ↵
    Barton SJ, Howe FA, Tomlins AM, Cudlip SA, Nicholson JK, Bell BA, Griffiths JR. Comparison of in vivo 1H MRS of human brain tumours with 1H HR-MAS spectroscopy of intact biopsy samples in vitro. Magma 1999;8:121-128
68. Cheng LL, Chang IW, Louis DN, Gonzalez RG. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 1998;58:1825-1832

    Abstract/FREE Full Text
69. Cheng LL, Ma MJ, Becerra L, Ptak T, Tracey I, Lackner A, Gonzaalez RG. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc of the Natl Acad of Sciences of the USA 1997;94:6408-6413

    Abstract/FREE Full Text